Octreotide studies: 134 papers with results
Page 3 of 3
Octreotide has 2,449 linked papers. PepBank read up to 120 of the most-cited studies that gave it to people, up to 20 other studies, and the main trials.
- Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man.
Fuessl HS · Digestion · 1987
Non-randomized trial · 2 results
- Fasting and post-prandial splanchnic blood flow is reduced by a somatostatin analogue (octreotide) in man.
Cooper AM · Clinical science (London, England : 1979) · 1991
Non-randomized trial · 9 results
- Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome.
De Waele K · European journal of endocrinology · 2008
Non-randomized trial · 10 results
- Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995.
Hoeldtke RD · Lancet (London, England) · 1986
Non-randomized trial · 7 results
- Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome.
Ladefoged K · Gut · 1989
Non-randomized trial · 7 results
- A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal.
Parkinson C · The Journal of clinical endocrinology and metabolism · 2002
Non-randomized trial · 8 results
- Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201-995 in acromegaly.
van Liessum PA · The Journal of clinical endocrinology and metabolism · 1989
Non-randomized trial · 4 results
- Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
Ambrosi B · Journal of endocrinological investigation · 1990
Non-randomized trial · 4 results
- Octreotide treatment of acromegaly. A randomized, multicenter study.
Ezzat S · Annals of internal medicine · 1992
Non-randomized trial · 20 results
- Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension.
Escorsell A · Gastroenterology · 2001
Non-randomized trial · 7 results
- Octreotide inhibits the meal-induced increases in the portal venous pressure of cirrhotic patients with portal hypertension: a double-blind, placebo-controlled study.
McCormick PA · Hepatology (Baltimore, Md.) · 1992
Non-randomized trial · 3 results
- Sandostatin LAR (microencapsulated octreotide acetate) in acromegaly: pharmacokinetic and pharmacodynamic relationships.
Grass P · Metabolism: clinical and experimental · 1996
Non-randomized trial · 5 results
- Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study.
Ronchi CL · Clinical endocrinology · 2007
Non-randomized trial · 15 results
- Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones.
Hussaini SH · Gut · 1996
Non-randomized trial · 7 results
- Treatment of orthostatic hypotension with midodrine and octreotide.
Hoeldtke RD · The Journal of clinical endocrinology and metabolism · 1998
Non-randomized trial · 2 results
- Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans.
Creutzfeldt W · The American journal of medicine · 1987
Non-randomized trial · 11 results
- Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide.
Casar-Borota O · The Journal of clinical endocrinology and metabolism · 2013
Observational study · 4 results
- Octreotide: a potent new non-opiate analgesic for intrathecal infusion.
Penn RD · Pain · 1992
Case report or series · 5 results
- Octreotide in the treatment of thoracic duct injuries.
Markham KM · The American surgeon · 2000
Animal study (in vivo) · dog · 7 results
- Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs.
Thanou M · Pharmaceutical research · 2001
Animal study (in vivo) · pig · 2 results
- SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.
Bauer W · Life sciences · 1982
Animal study (in vivo) · rat and rhesus monkey · 7 results
- Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.
Masyuk TV · Gastroenterology · 2007
Animal study (in vivo) · rat · 4 results
- Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases.
Masyuk TV · Hepatology (Baltimore, Md.) · 2013
Animal study (in vivo) · rat and mouse · 6 results
- Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation.
Pöll F · Molecular endocrinology (Baltimore, Md.) · 2010
Animal study (in vivo) · 9 results
- Octreotide and melatonin alleviate inflammasome-induced pyroptosis through inhibition of TLR4-NF-κB-NLRP3 pathway in hepatic ischemia/reperfusion injury.
El-Sisi AEE · Toxicology and applied pharmacology · 2021
Animal study (in vivo) · rat · 2 results
- The protection by octreotide against experimental ischemic stroke: up-regulated transcription factor Nrf2, HO-1 and down-regulated NF-κB expression.
Chen L · Brain research · 2012
Animal study (in vivo) · rat · 8 results
- Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995).
Danesi R · Clinical cancer research : an official journal of the American Association for Cancer Research · 1997
Animal study (in vivo) · chicken and rat · 5 results
- Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinomas.
Weckbecker G · Cancer research · 1994
Animal study (in vivo) · rat · 3 results
- A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus.
Vezzani A · Neuropharmacology · 1991
Animal study (in vivo) · rat · 10 results
- The effects of sandostatin and somatostatin on nociceptive transmission in the dorsal horn of the rat spinal cord.
Chapman V · Neuropeptides · 1992
Animal study (in vivo) · rat · 11 results
- Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.
Upp JR Jr · American journal of surgery · 1988
Animal study (in vivo) · mouse · 14 results
- Octreotide effectively decreases mucosal damage in experimental colitis.
Eliakim R · Gut · 1993
Animal study (in vivo) · rat · 6 results
- Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion.
Flyvbjerg A · Kidney international · 1992
Animal study (in vivo) · rat · 13 results
- Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass.
Fenske WK · International journal of obesity (2005) · 2012
Animal study (in vivo) · rat · 6 results